Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking Saxenda Adverse Reactions The most common adverse reactions, reported in 5% are nausea, diarrhea, constipation, vomiting, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, upper abdominal pain, pyrexia, and gastroenteritis Drug Interactions Saxenda causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications
Anti-nausea medications, dietary adjustments, and slower dose titration can all help reduce the frequency of vomiting.
Daily intake of Lactobacillus gasseri CP2305 improves mental, physical, and sleep quality among Japanese medical students enrolled in a cadaver dissection course
Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy

As with any injectable, use clean technique and consult your veterinarian before starting, particularly for animals competing under anti-doping or racing regulations